NIC
WST icon

Northwest Investment Counselors’s West Pharmaceutical WST Stock Holding History

Northwest Investment Counselors’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$30K Buy
+100
New +$30.6K 0.01% 297
2024
Q2 		– Sell
-100
Closed -$39.6K – 505
2024
Q1 		$39.6K Buy
+100
New +$37K 0.01% 253
2023
Q4 		– Sell
-100
Closed -$37.5K – 540
2023
Q3 		$37.5K Hold
100
– – 0.01% 255
2023
Q2 		$38.2K Hold
100
– – 0.01% 263
2023
Q1 		$34.6K Hold
100
– – 0.01% 274
2022
Q4 		$23.5K Hold
100
– – 0.01% 319
2022
Q3 		$25K Hold
100
– – 0.01% 285
2022
Q2 		$30K Hold
100
– – 0.01% 266
2022
Q1 		$41K Hold
100
– – 0.01% 252
2021
Q4 		$47K Buy
+100
New +$43K 0.01% 237
2021
Q2 		– Sell
-100
Closed -$28K – 448
2021
Q1 		$28K Buy
+100
New +$28.6K 0.01% 276
2020
Q4 		– Sell
-100
Closed -$27K – 438
2020
Q3 		$27K Buy
+100
New +$26.5K 0.01% 248
2019
Q4 		– Sell
-100
Closed -$14K – 502
2019
Q3 		$14K Buy
+100
New +$13.8K 0.01% 325

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northwest Investment Counselors's WST Position: Q3 2024 in Review

Northwest Investment Counselors opened a new position in West Pharmaceutical (WST) in Q3 2024: 100 shares worth $30K. The stake represents 0.01% of the portfolio and ranks #297 among its holdings. This is a return to the name: Northwest Investment Counselors previously reported a position in WST as recently as Q1 2024.

Northwest Investment Counselors first reported a position in WST in Q3 2019 and has held it in 13 quarters since. The position peaked at $47K in Q4 2021. 730 funds tracked by Wall St. Rank hold WST as of Q3 2024.

  • Northwest Investment Counselors held 100 shares of West Pharmaceutical worth $30K as of Q3 2024.
  • West Pharmaceutical was a new Northwest Investment Counselors position in Q3 2024.
  • West Pharmaceutical made up 0.01% of Northwest Investment Counselors's portfolio in Q3 2024, its #297 holding.
  • Northwest Investment Counselors first reported a position in West Pharmaceutical in Q3 2019 and has held it in 13 quarters since.
  • Northwest Investment Counselors's West Pharmaceutical position peaked at $47K in Q4 2021.
  • 730 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2024.

Based on Northwest Investment Counselors's 13F filing for Q3 2024, filed 21 Oct 2024.